Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals & Future Market Opportunity Outlook 2029

Alphamab Oncology
Amgen
AstraZeneca
Beijing Biocytogen
BiVictriX Therapeutics
Corellia AI
Debiopharm
Doma Bio
Genmab
Innovent Biologics
ProEn Therapeutics